Modular DHA Synthase Enzyme for Polyunsaturated Fatty Acid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid (DHA), from natural sources and chemical synthesis are insufficient for long-term commercial needs, and the biochemical basis of DHA synthesis in Crypthecodinium cohnii has not been well understood, lacking identified genes or proteins associated with DHA synthesis.
Innovation Solution
Identification of a modular Type I polyketide synthase (PKS) enzyme, specifically a docosahexaenoic acid synthase, in Crypthecodinium cohnii, which catalyzes de novo production of DHA using malonyl-CoA as a substrate without requiring molecular oxygen, and its expression in host organisms to enhance DHA production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional elongation and desaturation pathways are used for PUFA production, then existing enzymatic pathways can be utilized, but the production capacity is insufficient for long-term commercial needs
Solution Approach 1:
The patent divides the PUFA synthesis pathway into modular domains within a Type I polyketide synthase system. Each module contains specific enzymatic activities (ketosynthase, acyltransferase, dehydratase, enoylreductase, beta-keto reductase) that can be independently optimized and assembled. This modular architecture enables enhanced productivity by allowing systematic optimization of individual modules while maintaining overall pathway functionality, directly addressing the insufficient production capacity of conventional pathways.
2Productivity
If Type I polyketide synthase system is used for de novo PUFA synthesis, then production capacity is enhanced, but the system complexity increases compared to conventional pathways
Solution Approach 1:
The patent merges multiple enzymatic activities (ketosynthase, acyltransferase, dehydratase, enoylreductase, beta-keto reductase) into a single integrated Type I polyketide synthase complex. This consolidation reduces the number of separate enzymes and regulatory elements needed, simplifying the overall system architecture while maintaining enhanced productivity. The merged system operates as a coordinated unit, reducing complexity compared to having separate enzymes for each reaction step.
3Adaptability or versatility
If conventional desaturases are used for double bond formation, then oxygen-dependent reactions occur, but this limits the synthesis pathway flexibility and efficiency
Solution Approach 1:
The patent fundamentally changes the reaction parameters by replacing oxygen-dependent desaturase reactions with oxygen-independent Type I PKS-mediated dehydratase and enoylreductase reactions. This parameter change eliminates the requirement for molecular oxygen, allowing the pathway to operate under anaerobic conditions and reducing oxidative stress. The energy parameters are also optimized through the coordinated action of coupled reductase reactions that use NADPH efficiently, enhancing pathway versatility and reducing energy consumption.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modular DHA synthase enables efficient production of DHA in genetically modified organisms, overcoming the limitations of existing methods and providing a novel pathway for DHA synthesis, potentially increasing DHA accumulation in hosts.
Implementation Method 1
Identification of a modular Type I polyketide synthase (PKS) enzyme, specifically a docosahexaenoic acid synthase, in Crypthecodinium cohnii, which catalyzes de novo production of DHA using malonyl-CoA as a substrate without requiring molecular oxygen
Data Source
Figure 1A~1B
Figure 1C~2
Figure 3
AI summary
This disclosure concerns a novel modular docosahexaenoic acid (DHA) synthase and recombinant host organisms genetically modified with such synthase and one or more accessory proteins that allow for and/or improve the production of PUFAs in the host organism. The disclosure also concerns methods of making and using such organisms as well as products obtained from such organisms.